These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34313167)

  • 1. Burden of arrhythmia and silent ischemia in heart transplant patients with cardiac allograft vasculopathy.
    Berg K; Bjerre KP; Clemmensen TS; Løgstrup BB; Mølgaard H; Poulsen SH; Eiskjær H
    Scand Cardiovasc J; 2021 Oct; 55(5):300-307. PubMed ID: 34313167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
    Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
    J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet aggregation and response to aspirin therapy in cardiac allograft vasculopathy.
    Bjerre KP; Clemmensen TS; Berg K; Poulsen SH; Hvas AM; Grove EL; Løgstrup BB; Jakobsen L; Thim T; Kristensen SD; Eiskjær H
    J Heart Lung Transplant; 2020 Apr; 39(4):371-378. PubMed ID: 32067865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in Heart Transplant Patients According to the Grading Scheme Developed by the International Society for Heart and Lung Transplantation (ISHLT).
    Zielińska K; Kukulski L; Wróbel M; Przybyłowski P; Rokicka D; Strojek K
    Ann Transplant; 2022 Feb; 27():e933420. PubMed ID: 35165250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.
    Tremblay-Gravel M; Racine N; de Denus S; Ducharme A; Pelletier GB; Giraldeau G; Liszkowski M; Parent MC; Carrier M; Fortier A; White M
    JACC Heart Fail; 2017 Dec; 5(12):891-901. PubMed ID: 29191295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients.
    Nous FMA; Roest S; van Dijkman ED; Attrach M; Caliskan K; Brugts JJ; Nieman K; Hirsch A; Constantinescu AA; Manintveld OC; Budde RPJ
    Transpl Int; 2021 Oct; 34(10):1886-1894. PubMed ID: 34268796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular ultrasound for cardiac allograft vasculopathy detection.
    Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
    Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of longitudinal myocardial deformation by 2-dimensional speckle-tracking echocardiography in heart transplant recipients: relation to coronary allograft vasculopathy.
    Clemmensen TS; Løgstrup BB; Eiskjær H; Poulsen SH
    J Heart Lung Transplant; 2015 Feb; 34(2):195-203. PubMed ID: 25108908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis.
    D'Addese L; Cantor RS; Koehl D; Reardon L; Ameduri R; Bock M; Morrison A; White S; Wisotzkey B; Kirklin JK; Godown J
    J Heart Lung Transplant; 2023 Jan; 42(1):115-123. PubMed ID: 36328858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro- and macrovascular cardiac allograft vasculopathy in relation to 91 cardiovascular biomarkers in heart transplant recipients-An exploratory study.
    Bjerre KP; Clemmensen TS; Poulsen SH; Hvas AM; Holm NR; Grove EL; Bouchelouche K; Kristensen SD; Eiskjaer H
    Clin Transplant; 2021 Jan; 35(1):e14133. PubMed ID: 33128247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy.
    Nelson LM; Andreassen AK; Arora S; Andersson B; Gude E; Eiskjaer H; Rådegran G; Dellgren G; Gullestad L; Gustafsson F
    Transpl Int; 2020 May; 33(5):517-528. PubMed ID: 31958178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients.
    Nelson LM; Rossing K; Ihlemann N; Boesgaard S; Engstrøm T; Gustafsson F
    Clin Transplant; 2020 Dec; 34(12):e14124. PubMed ID: 33068292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients.
    Clemmensen TS; Eiskjær H; Løgstrup BB; Ilkjær LB; Poulsen SH
    J Heart Lung Transplant; 2017 May; 36(5):567-576. PubMed ID: 28089194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
    Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
    J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy.
    Foldyna B; Sandri M; Luecke C; Garbade J; Gohmann R; Hahn J; Fischer J; Gutberlet M; Lehmkuhl L
    Eur Radiol; 2020 Aug; 30(8):4317-4326. PubMed ID: 32179995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the development of cardiac allograft vasculopathy.
    Seki A; Fishbein MC
    Cardiovasc Pathol; 2014; 23(5):253-60. PubMed ID: 24972526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gadolinium enhancement assessed by cardiac magnetic resonance imaging in heart transplant recipients with different stages of cardiac allograft vasculopathy.
    Braggion-Santos MF; Lossnitzer D; Buss S; Lehrke S; Doesch A; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1125-32. PubMed ID: 24908664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cardiac allograft vasculopathy in heart and heart-lung transplantations: a 15-year retrospective study.
    Guihaire J; Mercier O; Flécher E; Aymami M; Fattal S; Chabanne C; Leroy Ladurie F; Lelong B; Cerrina J; Langanay T; Mussot S; Fabre D; De Latour B; Corbineau H; Verhoye JP; Dartevelle P; Leguerrier A; Fadel E
    J Heart Lung Transplant; 2014 Jun; 33(6):636-43. PubMed ID: 24630860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative 3D Analysis of Coronary Wall Morphology in Heart Transplant Patients: OCT-Assessed Cardiac Allograft Vasculopathy Progression.
    Chen Z; Pazdernik M; Zhang H; Wahle A; Guo Z; Bedanova H; Kautzner J; Melenovsky V; Kovarnik T; Sonka M
    Med Image Anal; 2018 Dec; 50():95-105. PubMed ID: 30253306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.